Workflow
LifeMD(LFMD)
icon
搜索文档
LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance According to Hagens Berman
Globenewswire· 2025-09-30 03:44
SAN FRANCISCO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- A new federal securities fraud class action lawsuit has been filed against LifeMD, Inc. (NASDAQ: LFMD) and its executives. The suit alleges the telehealth company presented a misleadingly optimistic picture of its financial health and growth, ultimately resulting in a dramatic stock price decline in August. The action was filed in the Eastern District of New York. The lawsuit, Johnston v. LifeMD, Inc., focuses on the period between May 7, 2025, and August 5, ...
SHAREHOLDER ALERT: Berger Montague Reminds LifeMD, Inc. (NASDAQ: LFMD) Investors of Class Action Lawsuit Deadline
Prnewswire· 2025-09-30 00:48
, /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired LifeMD securities during the Class Period may, no later than October 27, 2025, seek to be appointed as a lead plaintiff representative of the class. To lea ...
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2025 in LifeMD, Inc. Lawsuit - LFMD
Prnewswire· 2025-09-26 21:00
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of LifeMD, Inc. investors who were adversely affected by alleged securities fraud between May 7, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/lifemd-inc-lawsuit-submission-form?prid=169367&wire=4 Accessibility StatementSkip Navigation NEW YORK, Sept. 26, 2025 /PRNewswire/ -- Levi &Â Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the ...
LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
Globenewswire· 2025-09-26 04:06
公司近期动态 - 公司将于2025年10月9日在纽约大都会俱乐部参加ROTH第4届年度医疗保健机会会议 [1] - 公司管理层将在会议期间与投资者进行一对一会谈 [1] 公司业务概览 - 公司是虚拟初级护理服务的领先提供商 [2] - 业务范围涵盖远程医疗、实验室和药房服务接入以及超过200种病症的专科治疗 [2] - 专科治疗领域包括初级护理、男性和女性健康、体重管理和激素治疗 [2] 公司运营平台与能力 - 公司运营一个垂直整合的专有数字护理平台 [2] - 公司拥有一个覆盖美国50个州的附属医疗集团 [2] - 公司配备一个先进的附属复合药房和一个位于美国的患者护理中心 [2]
LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Prnewswire· 2025-09-26 03:51
Contact Us To Participate or Learn More:If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact: Howard G. Smith, Esq., Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Call us at: (215) 638-4847Email us at: [email protected], Visit our website at: www.howardsmithlaw.com. To be a member of the class action you need not ...
Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements According to Hagens Berman
Globenewswire· 2025-09-25 07:45
诉讼概况 - 针对远程医疗公司LifeMD提起新的联邦证券欺诈集体诉讼,指控公司及其高管向投资者提供关于其财务健康状况和增长前景的误导性信息 [1] - 诉讼案件名称为Johnston v LifeMD Inc,聚焦于2025年5月7日至2025年8月5日期间 [5] 指控内容 - 指控公司在2025年5月6日发布第一季度业绩并上调全年营收和调整后EBITDA指引时,做出了虚假和误导性陈述 [5] - 指控公司乐观的前景展望是虚假的,其引用的虚拟肥胖护理领域“定义类别的竞争护城河”以及RexMD品牌的强劲表现,未能如实反映关键的业务挑战 [5] - 指控公司当时未向投资者披露其RexMD部门客户获取成本上升以及体重管理业务退款率高于预期的问题 [6] 股价影响 - 指控的欺骗行为在2025年8月5日公司公布第二季度业绩时暴露,其营收和每股收益未达预期,并随后大幅下调了全年业绩指引 [7] - 在业绩电话会上,管理层将原因归咎于RexMD业务的“暂时性升高的客户获取成本”以及体重管理服务的患者退款问题 [7] - 在业绩公布后的第二天,LifeMD股价暴跌超过44% [7] 调查与背景 - 原告权利律师事务所Hagens Berman正在调查相关指控,调查重点在于LifeMD是否知晓但未能披露关键运营问题 [10] - Hagens Berman在此领域已为客户追回超过29亿美元 [13]
LIFEMD ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against LifeMD, Inc. and Encourages Investors to Contact the Firm
Globenewswire· 2025-09-25 05:19
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In LifeMD (LFMD) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar ...
LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – LFMD
Businesswire· 2025-09-24 22:59
LOS ANGELES--(BUSINESS WIRE)--LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – LFMD. ...
LifeMD: Set To Ride A Telehealth Tailwind (NASDAQ:LFMD)
Seeking Alpha· 2025-09-24 22:27
LifeMD (NASDAQ: LFMD ) is a smaller player in telehealth. LifeMD defines itself as a "direct-to-patient telehealth company providing a high-quality, cost-effective, and convenient way to access comprehensive, virtual, and in-home healthcare." Translation: LifeMD lets you see a doctor without leaving your house.I am a software developer by trade who focuses on finding value in the market wherever it may lie. I'm looking mainly in small caps for opportunities that provide asymmetric upside. I'm also intereste ...
LifeMD: Set To Ride A Telehealth Tailwind
Seeking Alpha· 2025-09-24 22:27
公司业务与定位 - LifeMD是一家在纳斯达克上市的小型远程医疗公司 股票代码为LFMD [1] - 公司将自身定位为“直接面向患者的远程医疗公司” 提供高质量、低成本、便捷的全面虚拟及居家医疗服务 [1] - 公司核心业务是让患者无需离开家即可看医生 [1] 分析师背景与投资方法 - 分析师为软件开发者背景 专注于在市场中寻找价值机会 主要寻找小盘股中具有不对称上涨潜力的机会 [2] - 投资目标包括通过投资产生收入 因此关注可持续的高股息收益率 [2] - 选择企业的标准包括内部人士买入和高内部人士持股、自由现金流长期增长历史、能导致转机或具有足够高账面价值的重大催化剂 [2] - 投资方式包括高收益债券和卖出看跌期权 但不进行做空操作 [2] - 主要受沃伦·巴菲特和彼得·林奇的投资哲学影响 倾向于永久持有投资 [2] - 投资目标是在牛市行情中匹配市场回报 并在市场下跌时产生超额收益 [2] - 分析师拥有经济学和金融学专业的理学学士学位 [2] 分析师持仓与免责 - 分析师通过股票、期权或其他衍生品对LFMD持有多头头寸 [3] - 文章内容为分析师个人观点 未因撰写此文获得除Seeking Alpha以外的报酬 [3] - 分析师与文章提及的任何公司均无业务关系 [3]